Igg-Dependent Hydrolysis of Myelin Basic Protein of Patients with Different Courses of Schizophrenia

Table 3

MBP-hydrolyzing activity levels in IgGs from schizophrenia patients and healthy control subjects.

Healthy control subjects, median [Q1-Q4] mg MBP/mg IgG/h	Patients with acute schizophrenia, median [Q1-Q4] mg MBP/mg IgG/h	Patients with schizophrenia in remission, median [Q1-Q4] mg MBP/mg IgG/h	value Kruskal–Wallis test
0.00 [0.00; 0.24]	1.026 [0.205; 3.372]	0.656 [0.279; 0.873]	0.0001

value from multiple comparisons with Kruskal–Wallis test including all groups of patients and healthy control group; significant at <0.05.